The central effectors of cell death in the immune system

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 781-828

  Rathmell, Jeffrey C ^a   Thompson, Craig B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apaf 1; Apoptosis; Bcl 2; Bcl x(L); Caspase; Caspase recruitment domain; CD95; Death domain; Death effector domain; Mitochondria; TNFR I

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BCL 2; PROTEIN BCL X; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; CELL DEATH; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE; MITOCHONDRION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASES; CELL DEATH; CYTOCHROME C GROUP; HUMANS; IMMUNE SYSTEM; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MITOCHONDRIA; NECROSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN;

EID: 0033009890     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.781     Document Type: Review

References (359)

1. Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-62
2. Councilman WT. 1890. Report on the etiology and prevention of yellow fever. In Public Health Bulletin, ed. GM Sternberg, 2:151-59. Washington, DC: US Govt. Print. Off.
3. Klion FM, Schaffner F. 1965. The ultrastructure of acidophilic "Councilman-like" bodies in the liver. Am. J. Pathol. 48:755-67
4. Kerr JFR. 1969. An electron-microscope study of liver cell necrosis due to heliotrine. J. Pathol. 97:557-62
5. Kerr JFR. 1971. Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. 105:13-20
6. Farbman AI. 1968. Electron microscope study of palate fusion in mouse embryos. Dev. Biol. 18:93-116
7. Kerr JFR, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-57
8. Duvall E, Wyllie AH. 1986. Death and the cell. Immunol. Today 7:115-19
9. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-36
10. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, et al. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-32
11. Marchetti P, Hirsch T, Zamzami N, Castedo M, Decaudin D, et al. 1996. Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol. 157:4830-36
12. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, et al. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533-44
13. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-37
14. Bossy-Wetzel E, Newmeyer DD, Green D. 1998. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:37-49
15. Skalka M, Matyasova J, Cejokova M. 1976. DNA in chromatin of irradiated lymphoid tissues degrades in vivo into regular fragments. FEBS Lett. 72:271-74
16. Wyllie AH. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-56
17. Wyllie AH, Morris RG, Smith AL, Dunlop D. 1984. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142:67-77
18. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie RCAA, et al. 1995. Early redistribution of plasma membrane phosphotidylserine is a general feature of apoptosis regardless of initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545-56
19. Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, et al. 1996. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol. 157:512-21
20. Verhoven B, Schlegel RA, Williamson P. 1995. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182:1597-601
21. Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthric LA, et al. 1997. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem. 272:26159-65
22. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. 1991. Interleukin 1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA 88:8485-89
23. Bellone M, Iezzi G, Rovere P, Galati G, Ronchetti A, et al. 1997. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391-99
24. Albert ML, Sauter B, Bhardwaj N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89
25. Bicknell GR, Cohen GM. 1995. Cleavage of DNA to large kilobase pair fragments occurs in some forms of necrosis as well as apoptosis. Biochem. Biophys. Res. Comm. 207:40-47
26. Dong Z, Sikumar P, Weinberg JM, Venkatachalam MA. 1997. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death: involvement of serine but not cysteine proteases. Am. J. Pathol. 151:1205-13
27. Didenko VV, Hornsby PJ. 1996. Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J. Cell Biol. 135:1369-76
28. Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. 1997. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1481-86
29. Lieberthal W, Menza SA, Levine JS. 1998. Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am. J. Physiol. 274:F315-27
30. Kass GEN, Eriksson JE, Weis M, Orrenius S, Chow SC. 1996. Chromatin condensation during apoptosis requires ATP. Biochem. J. 318:749-52
31. Griffith TS, Herndon JM, Green DR, Ferguson TA. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7-16
32. Hengartner MO, Horvitz HR. 1994. Programmed cell death in Caenorhabditis elegans. Curr. Opin. Gen. Dev. 4:581-86
33. Yuan J. Shaham S, Ledoux S, Ellis HM, Horvitz HR. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641-52
34. Cerrati DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, et al. 1992. Molecular cloning of the interleukin-1β-converting enzyme. Science 256:97-100
35. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768-74
36. Yuan J, Horvitz HR. 1992. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 116: 309-20
37. Vaux DL, Weissman IL, Kim SK. 1992. Prevention of programmed cell death in Caenorhabditis elegans by human Bcl-2. Science 258:1955-57
38. Hengartner MO, Horvitz HR. 1994. C. elegans cell death gene ced-9 encodes a functional homolog of mammalian protooncogene bcl-2. Cell 76:665-76
39. Chinnaiyan AR, O'Rourke K, Lane BR, Dixit VM. 1997. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275: 1122-26
40. Seshagiri S, Miller LK. 1997. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis. Curr. Biol. 7:455-60
41. Chinnaiyan AR, Chaudhary D, O'Rourke K, Koonin EV, Dixit VM. 1997. Role of CED-4 in the activation of CED-3. Nature 388:728-29
42. Irmler M, Hofmann K, Vaux D, Tschopp J. 1997. Direct physical-interaction between the Caenorhabditis elegans 'death proteins' CED-3 and CED-4. FEBS Lett. 406:189-90
43. Spector MS, Desnoyers S, Hoeppner DJ, Hengartner MO. 1997. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 385:653-56
44. Wu D, Wallen HD, Nuñez G. 1997. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275:1126-29
45. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-13
46. Miura M, Zhu H, Rotello R, Hartweig EA, Yuan J. 1993. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-60
47. Kumar S, Tomooka Y, Noda M. 1992. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Commun. 185:1155-61
48. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA. 1994. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev. 8:1613-26
49. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, et al. 1996. Human ICE/CED-3 protease nomenclature. Cell 87:171
50. 2 homodimer. Cell 78:343-52
51. Wilson KP, Black JF, Thomson JA, Kim EE, Griffith JP, et al. 1994. Structure and mechanism of interleukin-1β converting enzyme. Nature 370:270-75
52. Rotonda J, Nicholson DW, Fazil KM, Gallant M, Gareau Y, et al. 1996. The three dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. 3:619-25
53. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803-15
54. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-27
55. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, et al. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93:7464-69
56. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 74:609-19
57. Kitanaka C, Namiki T, Noguchi K, Mochizuki T, Kagaya S, et al. 1997. Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression: differential effects of Bcl-2 and BcI-xI, on Bax-induced caspase activation and apoptosis. Oncogene 15:1763-72
58. Xiang J, Chao DT, Korsmeyer SJ. 1996. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93:14559-63
59. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, et al. 1997. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15:1573-81
60. Monney L, Otter I, Olivier R, Ozer HL, Haas AL, et al. 1998. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J. Biol. Chem. 273:6121-31
61. Mills J, Stone NL, Erhardt J, Pittman RN. 1998. Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J. Cell Biol. 140:627-36
62. McCarthy NJ, Whyte MKB, Gillbert CS, Evan GI. 1997. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:215-27
63. Itoh N, Nagata S. 1993. A novel protein domain required for apoptosis. J. Biol. Chem. 268:10932-37
64. Tartaglia LA, Ayres M, Wong GH, Goeddel DV. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-53
65. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-65
66. Chaudhary PM, Eby M, Lasmin A, Bookwalter A, Murray J, et al. 1997. Death receptor 5, a new member of the TNF family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 7:821-30
67. Enari M, Hug H, Nagata S. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78-81
68. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, et al. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81-83
69. Longthorne VL, Williams GT. 1997. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J. 16:3805-12
70. Kuida K, Zheng TS, Na S, Kuan C, Yang D, et al. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-72
71. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, et al. 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:806-19
72. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, et al. 1998. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187:587-600
73. Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, et al. 1998. The caspase 3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol. 140:1485-95
74. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, et al. 1998. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94:339-52
75. Kuida K, Haydar TF, Kuan C-Y, Gu Y, Taya C, et al. 1998. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94:325-37
76. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, et al. 1998. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo 1, and DR3 and is lethal prenatally. Immunity 9:267-76
77. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, et al. 1995. Altered cytokine export and apoptosis in mice deficient in Interleukin-1β converting enzyme. Science 267:2000-3
78. Li P, Hamish A, Banerjee S, Franklin S, Herzog L, et al. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401-11
79. Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, et al. 1998. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12:1304-14
80. Wang S, Miura M, Jung Y, Zhu H, Yuan J. 1998. Murine Caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92:501-9
81. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. 1994. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739-50
82. Wang S, Miura M, Jung Y, Zhu H, Gagliardini V, et al. 1996. Identification and characterization of Ich-3, a member of the interleukin-1β converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 271:20580-87
83. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzong L, et al. 1997. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386:619-23
84. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, et al. 1997. Activation of Interferon-γ inducing factor mediated by Interleukin-1β converting enzyme. Science 275:206-9
85. Han Z, Hendrickson EA, Bremner TA, Wyche JH. 1997. A sequential two-step mechanism for the production of the mature p17:p12 form of Caspase-3 in vitro. J. Biol. Chem. 272:13432-36
86. Lens SMA, den Drijver BFA, Pötgens AJG, Tesselaar K, van Oers MHJ, et al. 1998. Dissection of pathways leading to antigen receptor-induced and Fas/CD95-induced apoptosis in human B cells. J. Immunol. 160:6083-92
87. Butt AJ, Harvey NL, Parasivam G, Kumar S. 1998. Dimerization and autoprocessing of the Nedd2 (Caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions. J. Biol. Chem. 273:6763-68
88. MacCorkle RA, Freeman KW, Spencer DM. 1998. Synthetic activation of caspases: artificial death switches. Proc. Natl. Acad. Sci. USA 95:3655-60
89. Martin DA, Siegel RM, Zheng L, Lenardo MJ. 1998. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHα1) death signal. J. Biol. Chem. 273:4345-49
90. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. 1998. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:2926-30
91. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES. 1998. Autoactivation of Procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1:949-57
92. Li P, Nijhawan D, Budihardjo I, Srinivasula S, Ahmad M, et al. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-89
93. Nicholson DW, Thornberry NA. 1997. Caspases: killer proteases. TIBS 22:299-306
94. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, et al. 1997. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:9677-82
95. Van de Craen M, Vandenabeele P, Declercq W, Van den Brande I, Van Loo G, et al. 1997. Characterization of seven murine caspase family members. FEBS Lett. 403:61-69
96. Humke EW, Dixit VM. 1998. ERICE, a novel FLICE-activatable caspase. J. Biol. Chem. 272:15702-7
97. Vincenz C, Dixit VM. 1997. Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J. Biol. Chem. 272:6578-83
98. Casiano CA, Martin SJ, Green DR, Tan EM. 1996. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J. Exp. Med. 184:765-70
99. Widmann C, Gibson S, Johnson GL, 1998. Caspase-dependent cleavage of signaling proteins during apoptosis: A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273:7141-47
100. Janicke RU, Ng P, Sprengart ML, Porter AG. 1998. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273:15540-45
101. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-31
102. Deak JC, Cross JV, Lewis M, Qian Y, Parrott LA, et al. 1998. Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1. Proc. Natl. Acad. Sci. USA 95:5595-600
103. Widmann C, Gerwins P, Johnson NL, Jarpe MB, Johnson GL. 1998. MEK Kinase 1, a substrate for DEVD-directed caspases is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 18:2416-29
104. Santoro MF, Annand RR, Robertson MM, Peng Y, Brady MJ, et al. 1998. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J. Biol. Chem. 273:13119-28
105. Holmström TH, Chow SC, Elo I, Coffey ET, Orrenius S, et al. 1998. Suppression of Fas/APO-1-mediated apoptosis by Mitogen-Activated Kinase signaling. J. Immunol. 160:2626-36
106. Zha J, Harado H, Yang E, Jockel J, Korsmeyer SJ. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 87:619-28
107. Datta SR, Dudek H, Tao X, Masters S, Fu H, et al. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-41
108. Beg AA, Baltimore D. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-84
109. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-89
110. Ravi R, Bedi A, Fuchs EJ, Bedi A. 1998. CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB. Cancer Res. 58:882-86
111. Tan X, Martin SJ, Green DR, Wang JYJ. 1997. Degradation of retinoblastoma protein in tumor necrosis factor-and CD95-induced cell death. J. Biol. Chem. 272:9613-16
112. Gottleib E, Oren M. 1998. p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J. 17:3587-96
113. Rhéaume E, Cohen LY, Uhlmann F, Lazure C, Alam A, et al. 1997. The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase-3-like protease during Fas-mediated apoptosis. EMBO J. 16:6346-54
114. Ubeda M, Habener JF. 1997. The large subunit of the DNA Replication Complex C (DSEB/RF-C140) cleaved and inactivated by caspase 3 (CPP32/YAMA) dur ing Fas-induced apoptosis. J. Biol. Chem. 272:19562-68
115. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. 1993. Specific proteolytic cleavage of Poly(ADP-ribose) Polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:3976-85
116. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-47
117. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, et al. 1995. Yama/ CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate Poly(ADP-Ribose) Polymerase. Cell 81:801-9
118. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43
119. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, et al. 1996. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1957-64
120. Han Z, Malik N, Carter T, Reeves WH, Wyche JH, et al. 1996. DNA-dependent Protein Kinase is a target for a CPP32-like apoptotic protease. J. Biol. Chem. 271:25035-40
121. Song Q, Lees-Miller SP, Kumar S, Zhang N, Chan DW, et al. 1996. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J. 15:3238-46
122. Flygare J, Armstrong RC, Wennborg A, Orsan S, Hellgren D. 1998. Proteolytic cleavage of HsRad51 during apoptosis. FEBS Lett. 427:247-51
123. Zhang Y, Center DM, Wu MH, Cruikshank WW, Yuan J, et al. 1998. Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 273:1144-49
124. Waterhouse N, Kumar S, Song Q, Strike P, Sparrow L, et al. 1996. Heteronuclear ribonucleoproteins C1 and C2, components of the spliceosome, are specific targets of Interleukin 1β-converting enzyme-like proteases in apoptosis. J. Biol. Chem. 271:29335-41
125. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A. 1994. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269:30757-60
126. Liu X, Zou H, Slaughter C, Wang X. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-84
127. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, et al. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50
128. Sakabira H, Enari M, Nagata S. 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96-99
129. Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L, et al. 1998. CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr. Biol. 8:537-40
130. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, et al. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966-68
131. Clem RJ, Cheng EH, Karp CL, Kirsch DG, Ueno K, et al. 1998. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA 95:554-59
132. Faucheu C, Diu A, Chan AWE, Blanchet A, Miossec C, et al. 1995. A novel human protease similar to the interleukin-1β converting enzyme induces apoptosis in transfected cells. EMBO J. 14:1914-22
133. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, Robertson R, Armstrong RC, et al. 1996. The Ced-3/Interleukin 1β converting enzyme-like homolog Mch6 and the Lamin-cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32. J. Biol. Chem. 271:27099-106
134. Orth K, O'Rourke K, Salvesen GS, Dixit VM. 1996. Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J. Biol. Chem. 271:20977-80
135. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, et al. 1996. Cleavage of hungtingtin by apo-pain, a proapoptolic cysteine protease, is modulated by the polyglutamine tract. Nature Gen. 13:442-49
136. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, et al. 1998. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273:9158-67
137. Loetscher H, Deuschle U, Brockhaus M, Reinhardt D, Nelboeck P, et al. 1997. Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272:20655-59
138. Palumbo GJ, Pickup DJ, Fredrickson TN, McIntyre LJ, Buller RM. 1989. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology 172:262-73
139. Gagliardini V, Fernandez P-A, Lee RKK, Drexler HCA, Rotello RJ, et al. 1994. Prevention of vertebrate neuronal death by the crmA gene. Science 263:826-28
140. Tewari M, Dixit VM. 1995. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:3255-60
141. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, et al. 1992. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the Interleukin-1β converting enzyme. Cell 69:597-604
142. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, et al. 1997. Target protease specificity of the viral serpin CrmA: analysis of five caspases. J. Biol. Chem. 272:7797-800
143. Clem RJ, Fechheimer M, Miller LK. 1991. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254:1388-90
144. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, et al. 1995. Inhibition of ICE family proteases by Baculovirus anti-apoptotic protein p35. Science 269:1885-88
145. Xue D, Horvitz HR. 1995. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377:248-51
146. Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, et al. 1994. Inhibition of Interleukin-1β converting enzyme by the Cowpox virus serpin CrmA. J. Biol. Chem. 169:19331-37
147. Clem RJ, Miller I.K. 1994. Control of programmed cell death by the Baculovirus genes p35 and iap. Mol. Cell. Biol. 14: 5212-22
148. Crook NE, Clem RJ, Miller LK. 1993. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67:2168-74
149. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, et al. 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349-53
150. Rothe M, Pan M-G, Henzel WJ, Ayres TM, Goeddel DV. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculovirus inhibitor of apoptosis proteins. Cell 83:1243-53
151. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL. 1996. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. USA 93:4974-78
152. Duckett CS, Nava VE, Gedrich RW, Clem RJ, Van Dongen JL, et al. 1996. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 15:2685-94
153. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300-4
154. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. 1997. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16:6914-25
155. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, et al. 1998. IAP's block apoptotic events by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17:2215-23
156. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, et al. 1998. A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem. 273:7787-90
157. Sanna MG, Duckett CS, Richter BWM, Thompson CB, Ulevitch RJ. 1998. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc. Natl. Acad. Sci. USA 95:6015-20
158. Chu Z-L, McKinsey TA, Liu L, Gentry JJ, Malim MH, et al. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor or apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA 94:10057-62
159. Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, et al. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:1172-76
160. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, et al. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-21
161. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-95
162. Shu H, Halpin DR, Goeddel DV. 1997. Casper is a FADD-and caspase-related inducer of apoptosis. Immunity 6:751-63
163. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM. 1997. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95-induced apoptosis. J. Biol. Chem. 272:17255-57
164. Srinivasula SM, Ahmad M, Ottilie S, Bullrich F, Banks S, et al. 1997. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272: 18542-45
165. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, et al. 1997. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272:19641-44
166. Inohara N, Koseki T, Hu Y, Chen S, Núñez G. 1997. CLARP, a death effector domain-containing protein, interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 94:10717-22
167. L and initiates cell death. Proc. Natl. Acad. Sci. USA 94:11333-38
168. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, et al. 1998. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, Apo-1) receptor complex. Cell Death Differ. 5:271-88
169. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615-23
170. Liu X, Naekyung K, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147-57
171. Hu Y, Benedict MA, Wu D, Inohara N, Núñez G. 1998. Bcl-xL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA 95:4386-91
172. L, and Apaf-1 form a ternary complex. J. Biol. Chem. 273: 5841-45
173. Huang DCS, Adams JM, Cory S. 1998. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 17:1029-39
174. Hofmann K, Bucher P, Tschopp J. 1997. The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. 22:155-56
175. Duan H, Dixit VM. 1997. RAIDD is a new 'death' adaptor molecule. Nature 385:86-89
176. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, et al. 1997. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res. 57: 615-19
177. Inohara N, del Peso L, Koseki T, Chen S, Núñez G. 1998. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273:12296-300
178. McCarthy JV, Ni J, Dixit VM. 1998. RIP2 is a novel NF-kappaB-activating and cell death inducing kinase. J. Biol. Chem. 273:16968-75
179. Thome M, Hofmann K, Burns K, Martino F, Bodmer J-L, et al. 1998. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8:885-88
180. Koseki T, Inohara N, Chen S, Nunez G. 1998. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc. Natl. Acad. Sci. USA 95:5156-60
181. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. 1994. The ancient regulatory-protein family of WD-repeat proteins. Nature 371:297-300
182. van der Biezen EA, Jones JDG. 1997. The NB-ARC domain: a novel signalling motif shared by plant resistance gene products and regulators of cell death in animals. Curr. Biol. 8:R226-27
183. Parker JE, Coleman MJ. 1997. Molecular intimacy between proteins specifying plant-pathogen recognition. Trends Biochem. Sci. 22:291-96
184. Camerini D, Walz G, Loenen WAM, Borst J, Seed B. 1991. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147:3165-69
185. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, et al. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421-27
186. Stamenkovic I, Clark EA, Seed B. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1403-10
187. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, et al. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and
188. Mallett S, Fossum S, Barclay AN. 1990. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes a molecule related to nerve growth factor receptor. EMBO J. 9:1063-68
189. Kwon BS, Weissman SM. 1989. cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 86:1963-67
190. Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, et al. 1986. Expression and structure of the human NGF receptor. Cell 47:545-54
191. Itoh N, Yonehara S, Ishii A, Sameshima M, Hase A, et al. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-43
192. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, et al. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. Biol. Chem. 267:10709-15
193. Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, et al. 1990. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351-59
194. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, et al. 1990. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-70
195. Chinnaiyan AM, O'Rourke K, Yu G-L, Lyons RH, Garg M, et al. 1996. Signal transduction by DR-3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990-92
196. Kiston J, Raven T, Jiang Y-P, Goeddel DV, Giles KM, et al. 1996. A death-domain-containing receptor that mediates apoptosis. Nature 384:372-75
197. cg, that complements the gld gene in induction of lymphadenopathy in the mouse. J. Exp. Med. 171:519-31
198. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-17
199. Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik SW. 1996. NRM structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 384:638-41
200. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-12
201. Boldin MP, Varfolomeev EĖ, Pancer Z, Mett IL, Camonis JH, et al. 1995. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795-98
202. Hsu H, Xiong J, Goeddel DV. 1995. The TNF Receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495-504
203. Hsu H, Shu H, Pan M, Goeddel DV. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transaction pathways. Cell 84:299-308
204. Rothe M, Sarma V, Dixit VM, Goeddel DV. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424-27
205. Liu Z, Hsu H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-76
206. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. 1996. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387-96
207. Stanger BZ, Leder P, Lee T, Kim E, Seed B. 1995. RIP: a novel protein containing a death domain that interacts with Fas/Apo-1 (CD95) in yeast and causes cell death. Cell 81:513-23
208. Ting AT, Pimentel-Muinos FX, Seed B. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 15:6189-96
209. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, et al. 1998. The death kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8:297-303
210. Sato T, Irie S, Kitada S, Reed JC. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411-15
211. Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, et al. 1997. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1837-49
212. Chu K, Niu X, Williams LT. 1995. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc. Natl. Acad. Sci. USA 97:11894-98
213. Yang X, Khosravi-Far R, Chang HY, Baltimore D. 1997. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067-76
214. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride W, et al. 1985. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899-906
215. Cleary ML, Sklar J. 1985. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82:7439-43
216. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. 1985. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-93
217. Cleary ML, Smith SD, Sklar J. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28
218. Vaux DL, Cory S, Adams JM. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-42
219. Yang E, Korsmeyer SJ. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386-401
220. Boise LH, Thompson CB. 1997. Bcl-xL can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94:3759-64
221. Gibson L, Holmgreen SP, Huang DCS, Bernard O, Copeland NG, et al. 1996. bcl-w, a novel member of the bcl-2 family, promotes survival. Oncogene 13:665-75
222. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW. 1993. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. USA 90:3516-20
223. Zhou P, Qian L, Kozopas KM, Craig RW. 1997. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89:630-43
224. Lin EY, Orlofsky A, Berger MS, Prystowsky MB. 1993. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151:1979-88
225. Choi SS, Park IC, Yun JW, Sung YC, Hong SI, et al. 1995. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11:1693-98
226. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, et al. 1993. Epstein-Barr virus-coded BIIRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90:8479-83
227. Rao L, Debbas M, Sabbatini P, Hockenberry D, Korsmeyer S, et al. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742-46
228. Boyd J, Malstrom S, Subramanian T, Venkatesch L, Schaeper U, et al. 1994. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79:341-51
229. Chiou SK, Tseng CC, Rao L, White E. 1994. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553-66
230. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, et al. 1995. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731-33
231. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, et al. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-36
232. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, et al. 1995. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374:736-39
233. Hsu S, Kaipia A, McGee E, Lomeli M, Hsuch AJW. 1997. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl. Acad. Sci. USA 94:12401-6
234. L. J. Biol. Chem. 273:8705-10
235. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, et al. 1995. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax, and promotes cell death. Cell 80:285-91
236. Han J, Sabbatini P, White E. 1996. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16:5857-64
237. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, et al. 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11:1921-28
238. Wang K, Yin X-M, Chao DT, Milliman CL, Korsmeyer SJ. 1996. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:2859-69
239. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, et al. 1998. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17:384-95
240. L. EMBO J. 16:1686-94
241. Hegde R, Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES. 1998. Blk, a BH3-containing mouse protein that interacts with Bcl-2 and Bcl-xL, is a potent death agonist. J. Biol. Chem. 273:7783-86
242. Chen G, Ray R, Dubik D, Shi L, Cizeau J, et al. 1997. The E1B 19K.Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J. Exp. Med. 186:1975-83
243. Yasuda M, Theodorakis P, Subramanian T, Chinnadurai G. 1998. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J. Biol. Chem. 273:12415-21
244. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, et al. 1996. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381:335-41
245. Kelekar A, Thompson CB. 1998. Bcl-2 family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8:324-30
246. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, et al. 1993. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes, Cancer Res. 53:4701-14
247. Nguyen M, Millar DG, Yong VW, Korsmeyer SJ, Shore GC. 1993. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem. 268:25265-68
248. Akao Y, Otsuki Y, Kataoka S, Ito Y, Tsujimoto Y. 1994. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 54:2468-71
249. L during apoptosis. Proc. Natl. Acad. Sci. USA 94:3669-72
250. Yin XM, Oltvai ZN, Korsmeyer SJ. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-23
251. Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, et al. 1997. Structure of Bcl-xL/Bak peptide complex reveals how regulators of apoptosis interact. Science 275:983-86
252. Simonen M, Keller H, Heim J. 1997. The BH3 domain of Bax is sufficient for interaction of Bax with itself and with other family members and it is required for induction of apoptosis. Eur. J. Biochem. 249:85-91
253. Zha H, Aime-Sempe C, Sato T, Reed JC. 1996. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271:7440-44
254. Oltvai Z, Korsmeyer SJ. 1994. Checkpoints of dueling dimers foil death wishes. Cell 79:189-92
255. Sedlak TW, Oltvai ZN, Wang K, Boise LH, Thompson CB, et al. 1995. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92:7834-38
256. L. Mol. Cell. Biol. 17:7040-46
257. Zha J, Harada H, Osipov K, Jockel J, Waksman G, et al. 1997. BH3 domain of BAD is required for heterodimerization with Bcl-XL and pro-apoptotic activity. J. Biol. Chem. 272:24101-4
258. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB. 1997. Identification of a novel regulatory domain in Bcl-xL and Bcl-2. EMBO J. 16:968-77
259. Haldar S, Jena N, Croce CM. 1995. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA 92:
260. Wang HG, Miyashita T, Takayama S, Sato T, Torigoe T, et al. 1994. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 9:2751-56
261. Wang H-G, Rapp UR, Reed JC. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629-38
262. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. 1996. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 56:1851-54
263. Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, et al. 1997. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272:25238-42
264. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, et al. 1998. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 18:3509-17
265. L and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182:821-28
266. Minn AJ, Vélez P, Schendel SL, Liang H, Muchmore SW, et al. 1997. Bcl-xL forms an ion channel in synthetic lipid membranes. Nature 385:353-57
267. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, et al. 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science 277:370-72
268. Schendel SL, Xie Z, Oblatt Montal M, Matsuyama S, Montal M, et al. 1997. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94:5113-18
269. Schlesinger PH, Gross A, Yin X-M, Yamamoto K, Saito M, et al. 1997. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. USA 94: 11357-62
270. Lam M, Bhat MB, Núñez G, Ma J, Distelhorst CW. 1998. Regulation of Bcl-xl channel activity by calcium. J. Biol. Chem. 273:17307-10
271. Pastorino JG, Chen S-T, Tafani M, Snyder JW, Farber JL. 1998. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273:7770-75
272. Jurgensmeier JM, Deveraux Q, Ellerby L, Bredesen D, Reed JC. 1998. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95:4997-5002
273. Garland JM, Halestrap A. 1997. Energy metabolism during apoptosis: Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J. Biol. Chem. 272:4680-88
274. Vander Heiden MG, Chandel NS, Schumacker PT, Thompson CB. 1998. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell. In press
275. Xie Z, Schendel S, Matusuyama S, Reed JC. 1998. Acidic pII promotes dimerization of Bcl-2 family proteins. Biochemistry 37:6410-18
276. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, et al. 1998. Two CD95 (APO-1/ Fas) signaling pathways. EMBO J. 17: 1675-87
277. Adachi S, Cross AR, Babior BM, Gottlieb RA. 1997. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J. Biol. Chem. 272:21878-82
278. Li H, Zhu H, Xu C, Yuan J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501
279. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-90
280. Zhivotovsky B, Orrenius S, Brustugun OT, Doskeland SO. 1998. Injected cytochrome c induces apoptosis. Nature 391:449-50
281. Rossé T, Olivier R, Monney L, Rager M, Conus S, et al. 1998. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391:496-99
282. Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, et al. 1997. Role for Bcl-xL as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:6939-42
283. Raff MC. 1992. Social controls on cell survival and death. Nature 356:397-400
284. Sprent J. 1973. Circulating T and B lymphocytes of the mouse. I. Migratory properties. Cell. Immunol. 7:10-39
285. Sprent J, Basten A. 1973. Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell. Immunol. 7:40-59
286. Sprent J, Schaefer M, Hurd M, Surh CD, Ron Y. 1991. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J. Exp. Med. 174:717-28
287. Cyster JG, Hartley SB, Goodnow CC. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371:389-95
288. Cyster JG, Goodnow CC. 1995. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 3:691-701
289. Fulcher DA, Lyons AB, Korn SL, Cook MC, Koleda C, et al. 1996. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183:2313-28
290. Lam K-P, Kühn R, Rajewsky K. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073-83
291. Markiewicz MA, Girao C, Opferman JT, Sun J, Hu Q, et al. 1998. Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 95:3065-70
292. Tanchot C, Lemonnier FA, Pérarnau B, Freitas AA, Rocha B. 1997. Differential requirements for survival and proliferation of CD8 naïve or memory T cells. Science 276:2057-61
293. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. 1991. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-88
294. Yeh TM, Korsmeyer SJ, Teale JM. 1991. Skewed B cell VH family repertoire in Bcl-2-Ig transgenic mice. Int. Immunol. 3:1329-33
295. Tao W, Teh S-J, McIhado I, Jirik F, Korsmeyer SJ, et al. 1994. The T cell receptor repertoire of CD4 8+ thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus. J. Exp. Med. 179:145-53
296. Fang W, Mueller DL, Pennell CA, Rivard JJ, Li YS, et al. 1996. Frequent aberrent immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity 4:291-99
297. Strasser A, Harris AW, von Boehmer H, Cory S. 1994. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc. Natl. Acad. Sci. USA 91:1376-80
298. Núñez G, Hockenbery D, McDonnell TJ, Sorensen CM, Korsmeyer SJ. 1991. Bcl-2 maintains B cell memory. Nature 353:71-73
299. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, et al. 1991. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88:8661-65
300. Fulcher DA, Basten A. 1997. Influences on the lifespan of B cell subpopulations defined by different phenotypes. Eur. J. Immunol. 27:1188-99
301. Cohen PL, Eisenberg RA. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-69
302. Nagata S, Golstein P. 1995. The Fas death factor. Science 267:1449-56
303. + T cells. Nature 376:181-84
304. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319-29
305. Fisher G, Rosenberg F, Straus S, Dale J, Middelton L, et al. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-46
306. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts A, Debatin K, et al. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-49
307. Sarin A, Wu M-L, Henkart PA. 1996. Different interleukin-1β converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184:2445-50
308. Alam A, Braun MY, Hartgers F, Lesage S, Cohen L, et al. 1997. Specific activation of the cysteine protease CPP32 during negative selection of T cells in the thymus. J. Exp. Med. 186:1503-12
309. Clayton LK, Ghendler Y, Mizoguchi E, Patch RJ, Ocain TD, et al. 1997. T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection. EMBO J. 16:2282-93
310. Andjelic S, Liou H-C. 1998. Antigen receptor-induced B lymphocyte apoptosis mediated via a protease of the caspase family. Eur. J. Immunol. 28:570-81
311. Graves JD, Draves KE, Craxton A, Krebs EG, Clark EA. 1998. A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas. J. Immunol. 161:168-74
312. Rickers A, Brockstedt E, Mapara MY, Otto A, Dörken B, et al. 1998. Inhibition of CPP32 blocks surface IgM-mediated apoptosis and D4-GDI cleavage in human BL60 Burkitt lymphoma cells. Eur. J. Immunol. 28:296-304
313. Strasser A, Harris AW, Cory S. 1991. BCL-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-99
314. Siegel RM, Katsumata M, Miyashita T, Louie DC, Greene MI, et al. 1992. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc. Natl. Acad. Sci. USA 89:7003-7
315. Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, et al. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325-35
316. Lang J, Arnold B, Hammerling G, Harris AW, Korsmeyer S, et al. 1997. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med. 186:1513-22
317. Fang W, Weintraub BC, Dunlap B, Garside P, Pape KA, et al. 1998. Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity 9:35-45
318. Woronicz JD, Calnan B, Ngo V, Winoto A. 1994. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367:277-80
319. Liu Z-G, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA. 1994. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281-84
320. Fernandes-Alnemri T, Litwack G, Alnemri ES. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian Interleukin-1β-converting enzyme. J. Biol. Chem. 269:30761-64
321. Kamens J, Paskind M, Hugunin M, Talanian RV, Allen H, et al. 1995. Identification and characterization of ICH-2, a novel member of the Interleukin-1β-converting enzyme family of cysteine proteases. J. Biol. Chem. 270:15250-56
322. relIII, members of the ICE/CED-3 family of cysteine proteases. J. Biol. Chem. 270:15870-76
323. Faucheu C, Blanchet A, Collard-Dutilleul V, Lalanne J, Dui-Hercend A. 1996. Identification of a cysteine protease closely related to interleukin-1β-converting enzyme. Eur. J. Biochem. 236:207-13
324. Fernandes-Alnemri T, Litwack G, Alnemri ES. 1995. Mch2, a new member of the apoptotic Ced3/Ice cysteine protease gene family. Cancer Res. 55:2737-42
325. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, et al. 1995. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55:6045-52
326. Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He W, et al. 1996. ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas-and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271:1621-25
327. Lippke JA, Gu Y, Sarnecki C, Caron PR, Su MS. 1996. Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271:1825-28
328. Duan H, Orth K, Chinnaiyan AM, Poirier GG, Froelich CJ, et al. 1996. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271:16720-24
329. Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, et al. 1996. Cleavage of lamin A by Mch2α but not CPP32: Multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA 93:8395-400
330. Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM. 1996. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271:16443-46
331. Rao L, Perez D, White E. 1996. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135:1441-55
332. Brancolini C, Benedetti M, Schneider C. 1995. Microfilament reorganization during apoptosis: role of Gas2, a possible substrate for ICE-like proteases. EMBO J. 14:5179-90
333. Cryns VL, Bergeron L, Zhu H, Li H, Yuan J. 1996. Specific cleavage of α-Fodrin during Fas-and Tumor Necrosis Factor-induced apoptosis is mediated by an Interleukin-1β-converting enzyme/Ced-3 protease distinct from the Poly (ADP-ribose) polymerase protease. J. Biol. Chem. 271:31277-82
334. Nath R, Raser KJ, Stafford D, Hajimohammadreza I, Posner A, et al. 1996. Non-erythroid α-spectrin breakdown by calpain and interleukin 1β-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319:683-90
335. Wen L, Fahrni JA, Troie S, Guan J, Orth K, et al. 1997. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272:26056-61
336. FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J. Exp. Med. 187:579-86
337. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, et al. 1997. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278:294-98
338. Caulín C, Salvesen GS, Oshima RG. 1997. Caspase cleavage of Keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 138:1379-94
339. Kayalor C, Örd T, Testa P, Zhong L, Bredsen DE. 1996. Cleavage of actin by interleukin 1β-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. USA 93:2234-38
340. Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW, et al. 1997. Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14:1007-12
341. Brancolini C, Lazarevic D, Rodriguez J, Schneider C. 1997. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of β-catenin. J. Cell Biol. 139:759-71
342. Hashimoto M, Inoue S, Ogawa S, Conrad C, Muramatsu M, et al. 1998. Rapid fragmentation of vimentin in human skin fibroblasts exposed to tamoxifen: a possible involvement of caspase 3, Biochem. Biophys. Res. Commun. 247:401-6
343. 2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:5073-77
344. King P, Goodbourn S. 1998. STAT1 is inactivated by a caspase. J. Biol. Chem. 273:8699-704
345. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, et al. 1996. Proteolytic activation of Protein Kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184:2399-404
346. Datta R, Kojima H, Yoshida K, Kufe D. 1997. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 272:20317-20
347. Na S, Chuang T, Cunningham A, Turi TG, Hanke JH, et al. 1996. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J. Biol. Chem. 271:11209-13
348. Lee N, Reinhard C, Halenbeck R, Roulston A, Shi T, et al. 1997. Activation of hPAK62 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc. Natl. Acad. Sci. USA 94:13642-47
349. Rudel T, Bokoch GM. 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276:1571-74
350. Chen L, Marechal V, Moreau J, Levine AJ, Chen J. 1997. Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J. Biol. Chem. 272:22966-73
351. Beyaert R, Kidd VJ, Cornelis S, Van de Craen M, Denecker G, et al. 1997. Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by Tumor Necrosis Factor. J. Biol. Chem. 272:11694-97
352. Zhou BB, Yuan J, Kirschner MW. 1998. Caspase-dependent activation of cyclin-dependent kinases during fas-induced apoptosis in jurkat cells. Proc. Natl. Acad. Sci. USA 95:6785-90
353. Cosulich SC, Horiuchi H, Zerial M, Clarke PR, Woodman PG. 1997. Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis. EMBO J. 16:6182-91
354. Piedrafita FJ, Phahl M. 1997. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol. Cell. Biol. 17:6348-58
355. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, et al. 1996. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J. 15:1012-20
356. Ng FW, Nguyen M, Kwan T, Branton PE, Nicholson DW, et al. 1997. p28 Bap31, a Bcl-2/Bcl-XL-and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell Biol. 139:327-38
357. Harvey KF, Harvey NL, Michael JM, Parasivam G, Waterhouse N, et al. 1998. Caspase-mediated cleavage of the ubiquitin-protein ligase Nedd4 during apoptosis. J. Biol. Chem. 273:13524-30
358. Salvesen GS, Dixit VM. 1997. Caspases: intracellular signaling by proteases. Cell 91:443-46
359. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, et al. 1998. Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis. Immunity 8:451-60